Suchergebnisse - "Polin, Lisa"

PubPharm (88)

1

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

enthalten in: Cancer research | 2024

von Su, Y. | Carter, J. | Li, X. | +31

2

Mitochondrial and cytosolic one-carbon metabolism is a targetable metabolic vulnerability in cisplatin-resistant ovarian cancer

enthalten in: Molecular cancer therapeutics | 2024

von Wallace-Povirk, A. | O'Connor, C. | Dekhne, A. | +13

3

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

enthalten in: Biochemical pharmacology | 2024

von Hurrish, K. | Su, Y. | Patel, S. | +26

UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954

4

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

enthalten in: Cancer cell international | 2023

von Ayodeji, S. | Bao, B. | Teslow, E. | +4

5

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Parajuli, P. | Rosati, R. | Mamdani, H. | +7

6

Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model

enthalten in: iScience | 2023

von Jacob, J. | Wei, K. | Bepler, G. | +17

7

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

enthalten in: NAR cancer | 2023

von Heyza, J. | Ekinci, E. | Lindquist, J. | +15

8

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment

enthalten in: Scientific reports | 2022

von Wallace-Povirk, A. | Rubinsak, L. | Malysa, A. | +13

9

RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA

enthalten in: Oncogene | 2021

von Block, C. | Mitchell, A. | Wu, L. | +9

10

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

enthalten in: Blood cancer journal | 2021

von Qiao, X. | Ma, J. | Knight, T. | +14

1
2
3
4
5
6
7
8
9
Nächster »
[9]